Iovance Biotherapeutics, Inc. lobbies on its own behalf. For Q1 2023 it reported $170K across 1 client report and lists 1 lobbyist across its filings. Issues include Medicare/Medicaid.
| Client | Reported | Issues |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | $170K | Medicare/Medicaid |
| Year | Reported | Clients |
|---|---|---|
| 2023 | $170K | 1 |
| 2022 | $780K | 1 |
Amounts are the filer's good-faith estimates, per report, and cannot be split by issue. See the Capitol Clarity rankings and method.